Microbic Biosystems

Microbix Biosystems is a Canadian life sciences company focused primarily on infectious-disease diagnostic inputs, external quality assessment products, and related sample-collection products. Its core commercial business supplies antigens used in immunoassays and molecular diagnostics, quality assessment products under the QAPs brand, and DxTM viral transport medium, alongside aseptic vial-filling services. The company also owns Kinlytic, a urokinase thrombolytic biologic being redeveloped with a commercialization partner for return to market. In addition, Microbix has developed enabling technologies such as VIRUSMAX and LumiSort that extend its virology and cell-processing capabilities. Overall, the business is best characterized as a revenue-generating diagnostics and biologics platform company with one notable therapeutic asset.